CVS, a classic defensive, is performing well, despite choppy macroeconomic conditions. Nothing has occurred within the last half-year to suggest that CVS will not be able to successfully incorporate recent acquisitions, and increase sales in key, new growth markets in the U.S.
Hence, as noted, if you're thinking about opening a "Mom & Pop' drug store next to CVS, think again. The First Call FY2009/FY2010 EPS estimates for CVS are $2.60 to $2.99.
Stock Analysis: CVS is a moderate-risk stock. CVS is an investment, not a trade. If you've already purchased CVS's shares, hold them. If not, consider buying a 25% position in CVS now; then buy another 25% in three months, if U.S. economic conditions don't worsen substantially. Under any circumstance, don't buy more than 50% of your CVS position before October 2009. Sell/Stop Loss if you were to buy shares in this company: $18.
- -
Disclosure: Lazzaro has no positions in stocks, but does own shares in two Pimco Bond Funds: PHDAX and PYMAX.
Google's plan for netbook PCs moves higher into the clouds
So long peak oil, here comes peak uranium
Black Friday expected to be strong, no promises for Christmas
